Home LiteratureArticle Details
PMID: 18836136 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

c-Jun N-terminal kinase 1 is required for the development of pulmonary fibrosis.

American journal of respiratory cell and molecular biology ·Vol. 40 ·No. 4 ·2009-04-00 ·Pages 422-32

Alcorn JF, van der Velden J, Brown AL, McElhinney B, Irvin CG, Janssen-Heininger YM

Abstract

Collagen deposition is observed in a diverse set of pulmonary diseases, and the unraveling of the molecular signaling pathways that facilitate collagen deposition represents an ongoing area of investigation. The stress-activated protein kinase, c-Jun N-terminal kinase 1 (JNK1), is activated by a large variety of cellular stresses and environmental insults. Recent work from our laboratory demonstrated the critical role of JNK1 in epithelial to mesenchymal transition. The goal of the present study was to examine the involvement of JNK1 in subepithelial collagen deposition in mice subjected to models of allergic airways disease and interstitial pulmonary fibrosis. Activation of JNK was slightly enhanced in lungs from mice subjected to sensitization and challenge with ovalbumin (Ova), and predominant localization of phospho-JNK was observed in the bronchial epithelium. While mice lacking JNK1 (JNK1-/- mice) displayed enhanced lung inflammation and cytokine production compared with wild-type (WT) mice, JNK1-/- mice accumulated less subepithelial collagen deposition in response to antigen, and showed decreased expression of profibrotic genes compared with WT animals. Furthermore, transforming growth factor (TGF)-beta1 content in the bronchoalveolar lavage was diminished in JNK1-/- mice compared with WT animals subjected to antigen. Finally, we demonstrated that mice lacking JNK1 were protected against TGF-beta1 and bleomycin-induced pro-fibrotic gene expression and pulmonary fibrosis. Collectively, these findings demonstrate an important requirement for JNK1 in promoting collagen deposition in multiple models of fibrosis.

MeSH Terms
Animals Antigens/immunology Bleomycin Collagen/metabolism Enzyme Activation/drug effects Epithelium/drug effects,enzymology,pathology Gene Expression Regulation/drug effects Immunization Lung/drug effects,enzymology,immunology,pathology Metaplasia/enzymology,pathology Mice Mice, Inbred C57BL Mitogen-Activated Protein Kinase 8/deficiency,metabolism Mucus/drug effects,enzymology Ovalbumin/immunology Phosphorylation/drug effects Pulmonary Fibrosis/chemically induced,enzymology,genetics,pathology Transforming Growth Factor beta1/administration & dosage,metabolism,pharmacology
Chemicals
Antigens Transforming Growth Factor beta1 Bleomycin Ovalbumin Collagen Mitogen-Activated Protein Kinase 8
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Alcorn John F
Department of Pathology, University of Vermont, Burlington, VT 05405, USA.
van der Velden Jos
Brown Amy L
McElhinney Brian
Irvin Charles G
Janssen-Heininger Yvonne M W
References (72)
72 references, click to expand
  1. Dual-immunohistochemistry provides little evidence for epithelial-mesenchymal transition in pulmonary fibrosis.
    Histochem Cell Biol. 2008 Apr;129(4):453-62 PMID: 18236067
  2. Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-beta1.
    J Cell Sci. 2008 Apr 1;121(Pt 7):1036-45 PMID: 18334556
  3. Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1.
    Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10525-30 PMID: 18641127
  4. TGF-beta1 activates MAP kinase in human mesangial cells: a possible role in collagen expression.
    Kidney Int. 1999 Nov;56(5):1710-20 PMID: 10571779
  5. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.
    J Biol Chem. 2001 Jun 8;276(23):19945-53 PMID: 11262418
  6. Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung.
    Thorax. 2001 Jul;56(7):549-56 PMID: 11413354
  7. Is Smad3 a major player in signal transduction pathways leading to fibrogenesis?
    Chest. 2001 Jul;120(1 Suppl):43S-47S PMID: 11451911
  8. Activation of the TGF-beta/activin-Smad2 pathway during allergic airway inflammation.
    Am J Respir Cell Mol Biol. 2001 Jul;25(1):60-8 PMID: 11472976
  9. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73.
    Nature. 1991 Dec 12;354(6353):494-6 PMID: 1749429
  10. Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airflow obstruction.
    Am J Respir Crit Care Med. 1995 Sep;152(3):865-71 PMID: 7663797
  11. TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study.
    Am J Respir Cell Mol Biol. 1996 Feb;14(2):131-8 PMID: 8630262
  12. Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor beta-mediated signaling.
    J Biol Chem. 1997 Jan 17;272(3):1429-32 PMID: 8999807
  13. Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis.
    Am J Pathol. 1997 Mar;150(3):981-91 PMID: 9060836
  14. Airways remodeling is a distinctive feature of asthma and is related to severity of disease.
    Chest. 1997 Apr;111(4):852-7 PMID: 9106559
  15. Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis.
    Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):591-9 PMID: 9279245
  16. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma.
    Am J Respir Cell Mol Biol. 1997 Sep;17(3):326-33 PMID: 9308919
  17. Expression of growth factors and remodelling of the airway wall in bronchial asthma.
    Thorax. 1998 Jan;53(1):21-7 PMID: 9577517
  18. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription.
    Nature. 1998 Aug 27;394(6696):909-13 PMID: 9732876
  19. Defective T cell differentiation in the absence of Jnk1.
    Science. 1998 Dec 11;282(5396):2092-5 PMID: 9851932
  20. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway.
    EMBO J. 1999 Mar 1;18(5):1345-56 PMID: 10064600
  21. In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosyphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation.
    J Allergy Clin Immunol. 1999 Sep;104(3 Pt 1):565-74 PMID: 10482829
  22. Airway remodeling in asthma.
    J Clin Invest. 1999 Oct;104(8):1001-6 PMID: 10525034
  23. Interleukin-13 in asthma pathogenesis.
    Immunol Rev. 2004 Dec;202:175-90 PMID: 15546393
  24. Acute allergen-induced airway remodeling in atopic asthma.
    Am J Respir Cell Mol Biol. 2004 Dec;31(6):626-32 PMID: 15333330
  25. Regulation of TGF-beta 1-induced connective tissue growth factor expression in airway smooth muscle cells.
    Am J Physiol Lung Cell Mol Physiol. 2005 Jan;288(1):L68-76 PMID: 15377500
  26. Potential role of c-Jun NH2-terminal kinase in allergic airway inflammation and remodelling: effects of SP600125.
    Eur J Pharmacol. 2005 Jan 4;506(3):273-83 PMID: 15627438
  27. Epithelial expression of profibrotic mediators in a model of allergen-induced airway remodeling.
    Am J Respir Cell Mol Biol. 2005 Feb;32(2):99-107 PMID: 15563691
  28. Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway.
    J Immunol. 2005 May 1;174(9):5774-80 PMID: 15843580
  29. Pulmonary fibrosis: searching for model answers.
    Am J Respir Cell Mol Biol. 2005 Jul;33(1):9-13 PMID: 15964990
  30. Disabled-2 (Dab2) mediates transforming growth factor beta (TGFbeta)-stimulated fibronectin synthesis through TGFbeta-activated kinase 1 and activation of the JNK pathway.
    J Biol Chem. 2005 Jul 8;280(27):25920-7 PMID: 15894542
  31. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
    Respir Res. 2005;6:56 PMID: 15946381
  32. Mucus and MUC in asthma.
    Curr Opin Pulm Med. 2006 Jan;12(1):1-6 PMID: 16357571
  33. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1).
    J Exp Med. 2001 Sep 17;194(6):809-21 PMID: 11560996
  34. The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma.
    Eur Respir J. 2006 Jan;27(1):208-29 PMID: 16387953
  35. Targeting genes for treatment in idiopathic pulmonary fibrosis: challenges and opportunities, promises and pitfalls.
    Proc Am Thorac Soc. 2006 Jun;3(4):389-93 PMID: 16738206
  36. Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis.
    Proc Am Thorac Soc. 2006 Jul;3(5):413-7 PMID: 16799084
  37. Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors.
    Mol Cell Biol. 2006 Jul;26(14):5518-27 PMID: 16809784
  38. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix.
    Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13180-5 PMID: 16924102
  39. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice.
    Am J Physiol Lung Cell Mol Physiol. 2002 Mar;282(3):L585-93 PMID: 11839555
  40. Activation of TGF-beta/Smad2 signaling is associated with airway remodeling in asthma.
    J Allergy Clin Immunol. 2002 Aug;110(2):249-54 PMID: 12170265
  41. MAP kinase activation and apoptosis in lung tissues from patients with idiopathic pulmonary fibrosis.
    J Pathol. 2002 Nov;198(3):388-96 PMID: 12375272
  42. Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses.
    J Biol Chem. 2003 Feb 7;278(6):3751-61 PMID: 12446693
  43. Airway remodeling in asthma: new insights.
    J Allergy Clin Immunol. 2003 Feb;111(2):215-25; quiz 226 PMID: 12589337
  44. C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts.
    Am J Respir Cell Mol Biol. 2003 Jun;28(6):754-61 PMID: 12760970
  45. TGF-beta1 causes airway fibrosis and increased collagen I and III mRNA in mice.
    Thorax. 2003 Sep;58(9):772-7 PMID: 12947136
  46. Smad-dependent and Smad-independent pathways in TGF-beta family signalling.
    Nature. 2003 Oct 9;425(6958):577-84 PMID: 14534577
  47. Hydrogen peroxide signaling through tumor necrosis factor receptor 1 leads to selective activation of c-Jun N-terminal kinase.
    J Biol Chem. 2003 Nov 7;278(45):44091-6 PMID: 12939259
  48. Overexpression of tumor necrosis factor-alpha diminishes pulmonary fibrosis induced by bleomycin or transforming growth factor-beta.
    Am J Respir Cell Mol Biol. 2003 Dec;29(6):669-76 PMID: 12816730
  49. Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma.
    Am J Respir Crit Care Med. 2004 Jan 15;169(2):214-9 PMID: 14597484
  50. The role of transforming growth factor beta in lung development and disease.
    Chest. 2004 Feb;125(2):754-65 PMID: 14769761
  51. Inhibition of airway remodeling in IL-5-deficient mice.
    J Clin Invest. 2004 Feb;113(4):551-60 PMID: 14966564
  52. Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on alpha-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts.
    Clin Exp Allergy. 2004 Mar;34(3):437-44 PMID: 15005738
  53. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor.
    J Cell Physiol. 2004 May;199(2):284-92 PMID: 15040011
  54. Expression of growth factors by airway epithelial cells in a model of chronic asthma: regulation and relationship to subepithelial fibrosis.
    Clin Exp Allergy. 2004 Apr;34(4):567-75 PMID: 15080809
  55. TGF-beta signaling and the fibrotic response.
    FASEB J. 2004 May;18(7):816-27 PMID: 15117886
  56. Effect of an inhibitor of Jun N-terminal protein kinase, SP600125, in single allergen challenge in sensitized rats.
    Immunology. 2004 Jul;112(3):446-53 PMID: 15196213
  57. Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice.
    Am J Respir Cell Mol Biol. 2004 Jul;31(1):62-8 PMID: 14975941
  58. Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis.
    J Immunol. 2004 Aug 1;173(3):2099-108 PMID: 15265946
  59. Fibrotic disease and the T(H)1/T(H)2 paradigm.
    Nat Rev Immunol. 2004 Aug;4(8):583-94 PMID: 15286725
  60. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis.
    J Exp Med. 2004 Aug 2;200(3):377-89 PMID: 15289506
  61. Airway remodeling: lessons from animal models.
    Clin Rev Allergy Immunol. 2004 Aug;27(1):3-21 PMID: 15347847
  62. TGF-beta and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions.
    Oncogene. 2004 Sep 23;23(44):7416-29 PMID: 15326485
  63. A simple and sensitive method for the quantitative estimation of collagen.
    Anal Biochem. 1979 Apr 1;94(1):96-9 PMID: 88913
  64. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis.
    J Exp Med. 2006 Dec 25;203(13):2895-906 PMID: 17178917
  65. Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse.
    Respir Res. 2007;8:1 PMID: 17207287
  66. Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta1 induced collagen gene expression.
    J Cell Physiol. 2007 Jun;211(3):585-9 PMID: 17387717
  67. The c-jun kinase/stress-activated pathway: regulation, function and role in human disease.
    Biochim Biophys Acta. 2007 Aug;1773(8):1341-8 PMID: 17306896
  68. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease.
    Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L525-34 PMID: 17631612
  69. Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?
    Eur Respir J. 2007 Nov;30(5):835-9 PMID: 17978154
  70. Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease.
    Am J Respir Crit Care Med. 2007 Nov 15;176(10):974-82 PMID: 17761617
  71. The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis.
    Antioxid Redox Signal. 2008 Feb;10(2):287-301 PMID: 17961066
  72. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
    Int J Biochem Cell Biol. 2008;40(3):362-82 PMID: 17936056
Article Info
Journal
American journal of respiratory cell and molecular biology
Abbr.
Am J Respir Cell Mol Biol
ISSN
1535-4989
Published
2009-04-00
Epub
2008-00-03
Pages
422-32
Language
English
Region
United States
NLM ID
8917225
PMCID
PMC2660560
Subset
IM
Grants
NHLBI NIH HHS · F32 HL-082121 · United States
NHLBI NIH HHS · R01 HL085464 · United States
NHLBI NIH HHS · R01 HL-60014 · United States
NHLBI NIH HHS · R01 HL-079331 · United States
PHS HHS · P20 RL 15557 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com